Evidence map›Paper›PMID 28867508›Full record

ArticleVaccine2017

Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.

Deshayne B Fell, Eduardo Azziz-Baumgartner, Michael G Baker, Maneesh Batra, Julien Beauté, Philippe Beutels, Niranjan Bhat, Zulfiqar A Bhutta, Cheryl Cohen, Bremen De Mucio and 16 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05996549 (Acceptability, Cost-Effectiveness, and Capacity of a Facility-Based Seasonal Influenza Vaccination), which is not on this map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05996549 phase4unknown statusnot on this mapstarted 2022, after this paper: background citation

Acceptability, Cost-Effectiveness, and Capacity of a Facility-Based Seasonal Influenza Vaccination: A Study in Selected Hospitals of Bangladesh

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2022 to 2024Enrolled2,567ConditionsInfluenza Vaccine, Cost-Effectiveness, VaccinationArmsQuadrivalent Influenza Vaccine
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Association Between Influenza Vaccination and SARS-CoV-2 Infection.American journal of reproductive immunology (New York, N.Y. : 1989) · 2024
    Article
  16. Determinants of non-vaccination against seasonal influenza during pregnancy.Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 13 countries.

Deshayne B FellSchool of Epidemiology, Public Health and Preventive Medicine, University of Ottawa and Children's Hospital of Eastern Ontario (CHEO) Research Institute, Canada. Electronic address: dfell@cheo.on.ca.
Eduardo Azziz-BaumgartnerInfluenza Division, Centers for Disease Control and Prevention, USA. Electronic address: eha9@cdc.gov.
Michael G BakerDepartment of Public Health, University of Otago, New Zealand. Electronic address: michael.baker@otago.ac.nz.
Maneesh BatraDepartment of Pediatrics-Neonatology, University of Washington School of Medicine, USA. Electronic address: maneesh.batra@seattlechildrens.org.
Julien BeautéEuropean Centre for Disease Prevention and Control (ECDC), Sweden. Electronic address: julien.beaute@ecdc.europa.eu.
Philippe BeutelsCentre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium. Electronic address: philippe.beutels@uantwerpen.be.
Niranjan BhatCenter for Vaccine Innovation and Access, PATH, USA. Electronic address: nbhat@path.org.
Zulfiqar A BhuttaCentre for Global Child Health, Hospital for Sick Children, Canada; Center of Excellence in Women & Child Health, The Aga Khan University, Pakistan. Electronic address: Zulfiqar.bhutta@sickkkids.ca.
Cheryl CohenNational Institute for Communicable Diseases, National Health Laboratory Service, South Africa; School of Public Health, University of the Witwatersrand, South Africa. Electronic address: cherylc@nicd.ac.za.
Bremen De MucioLatin American Center for Perinatology, Women and Reproductive Health, Panamerican Health Organization, Uruguay. Electronic address: demuciob@paho.org.
Bradford D GessnerAgence de Médecine Préventive, France. Electronic address: bgessner@aamp.org.
Michael G GravettDepartment of Obstetrics and Gynecology, University of Washington, USA. Electronic address: gravettm@uw.edu.
Mark A KatzMedical School for International Health and Department of Health Systems Management, Ben Gurion University of the Negev, Israel; School of Public Health, University of Michigan, USA. Electronic address: katzmar@post.bgu.ac.il.
Marian KnightNational Perinatal Epidemiology Unit, University of Oxford, UK. Electronic address: marian.knight@npeu.ox.ac.uk.
Vernon J LeeSaw Swee Hock School of Public Health, National University of Singapore, Singapore. Electronic address: vernonljm@hotmail.com.
Mark LoebInstitute for Infectious Disease Research, McMaster University, Canada. Electronic address: loebm@mcmaster.ca.
Johannes M LuteijnQueen Mary, University of London, UK. Electronic address: j.m.luteijn@qmul.ac.uk.
Helen MarshallRobinson Research Institute and Adelaide Medical School, University of Adelaide and Women's and Children's Health Network, Australia. Electronic address: helen.marshall@adelaide.edu.au.
Harish NairUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh, UK. Electronic address: harish.nair@ed.ac.uk.
Kevin PottieDepartment of Family Medicine, University of Ottawa, Canada. Electronic address: kpottie@uottawa.ca.
Rehana A SalamSouth Australian Health and Medical Research Institute, University of Adelaide, Australia; Division of Women and Child Health, Aga Khan University, Pakistan. Electronic address: rehana.salam@aku.edu.
David A SavitzDepartments of Epidemiology and Obstetrics and Gynecology, Brown University, USA. Electronic address: david_savitz@brown.edu.
Suzanne J SerruyaLatin American Center for Perinatology, Women and Reproductive Health, Panamerican Health Organization, Uruguay. Electronic address: serruyas@paho.org.
Becky SkidmoreIndependent Information Specialist, Canada. Electronic address: bskidmore@rogers.com.
Justin R OrtizInitiative for Vaccine Research, World Health Organization, Switzerland. Electronic address: ortizj@who.int.
WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling
Aga Khan University · PKUniversity of Ottawa · CAUniversity of Washington · USAgence de Médecine Préventive · FRBen-Gurion University of the Negev · ILCenters for Disease Control and Prevention · USEuropean Centre for Disease Prevention and Control · SEJohn Brown University · USMcMaster University · CANational University Health System · SGProgram for Appropriate Technology in Health · USQueen Mary University of London · GBUniversity of Adelaide · AUUniversity of Antwerp · BEUniversity of Edinburgh · GBUniversity of Otago · NZUniversity of Oxford · GBUniversity of the Witwatersrand · ZAWorld Health Organization · CH

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
NCEZID CDC HHS U50 CK000431NCIRD CDC HHS U01 IP001048World Health Organization 001
6 · The paper itself

Abstract

From 2014 to 2017, the World Health Organization convened a working group to evaluate influenza disease burden and vaccine efficacy to inform estimates of maternal influenza immunization program impact. The group evaluated existing systematic reviews and relevant primary studies, and conducted four new systematic reviews. There was strong evidence that maternal influenza immunization prevented influenza illness in pregnant women and their infants, although data on severe illness prevention were lacking. The limited number of studies reporting influenza incidence in pregnant women and infants under six months had highly variable estimates and underrepresented low- and middle-income countries. The evidence that maternal influenza immunization reduces the risk of adverse birth outcomes was conflicting, and many observational studies were subject to substantial bias. The lack of scientific clarity regarding disease burden or magnitude of vaccine efficacy against severe illness poses challenges for robust estimation of the potential impact of maternal influenza immunization programs.

Indexed as

FemaleHumansImmunization ProgramsInfantInfluenza, HumanInfluenza VaccinesPregnancyPregnancy Complications, InfectiousVaccinationWorld Health OrganizationInfluenza VaccinesImmunizationInfantsInfluenzaPregnancy

Identifiers

PMID28867508
PMCPMC8274347
OpenAlexW2750945775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.